Vietnam performs first successful partial artificial heart implantation
The surgery lasted four hours. Two weeks post-implantation, the patient was able to walk and manage daily activities independently and is currently being guided through specialised care procedures in preparation for discharge.
Doctors at 108 Military Central Hospital perform implantation of a third-generation partial artificial heart device to a patient. (Photo: Vietnam+)
Hanoi (VNA) - The 108 Military Central Hospital on April 12 announced that its medical team had successfully performed Vietnam’s first implantation of a third-generation partial artificial heart device (LVAD – HeartMate 3). This landmark achievem🔯ent brings Vietnam’s medical capabilities closer to those of advanced healthcare systems worldwide.
In March 2025, 46-year-old H.T.X from Thanh Hoa province was diagnosed with severe heart failure (with an ejection fraction of only 19%) due to dilated cardiomyopathy. Her condition was further complicated by a previous stroke and a blocked right subclavian artery.
The patient had lived with end-stage heart failure for many years and had undergone the best available drug therapies, yet her health had continued to deteriorate. She suffered from acute shortness of breath and recurrent pleural effusion, often requiring emergency hospitalisation.
Following extensive consultations with both domestic and international experts, the patient was deemed a suitable candidate for the implantation of a third-generation Left Ventricular Assist Device (LVAD). This cutting-edge mechanical pump supports the left side of the heart, pumping blood from the heart to the aorta. Its advanced design reduces the risk of blood clots and haemolysis and is powered by an external battery via a connecting cable. Clinical studies have shown that LVADs significantly extend both the lifespan and quality of life for patients with advanced heart failure.
Within two weeks of the surgery, the patient had regained full independence in daily activities and is now preparing for discharge. (Photo: Vietnam+)
The operation was carried out by doctors from the Military Central Hospital 108, under the guidance of Professor Jan D. Schmitto, President of the European Society for Mechanical Circulatory Support.
Professor Schmitto was the first in the world to successfully implant a HeartMate 3 LVAD in 2014, with the patient still living a normal life 11 years later.
The procedure lasted four hours, and within two weeks of the surgery, the patient had regained full independence in daily activities and is now preparing for discharge.
Dr Dang Viet Duc, Deputy Director of the Cardiovascular Institute, noted that the HeartMate 3 LVAD is currently among the most advanced and sophisticated cardiovascular technologies available. By assisting the heart’s pumping function, it improves blood flow to vital organs, allowing patients to resume a normal lifestyle.
This successful operation offers hope to thousands of patients with end-stage heart failure—many of whom have previously had no option but to wait for a heart transplant. Although organ donation in Vietnam has improved, the number of available hearts remains far lower than the number of patients in need.
Reflecting on her recovery, patient H.T.X shared, "Before, every hospital visit came with the fear that my heart might stop at any moment. I’m deeply grateful to the doctors, nurses, hospital staff, and international experts who gave me a new lease of life. I feel healthy again and am looking forward to going home."
This milestone marks a major breakthrough for cardiac surgery in Vietnam. It highlights both the country’s growing medical expertise and the hospital’s strategic investment in high-tech healthcare development. The success of this case also lays the groundwork for broader application of advanced techniques across different medical specialities, encouraging multi-disciplinary collaboration in research and treatment to better serve patient needs.
The Military Central Hospital 108 is currently the only medical facility in Vietnam authorised to routinely perform LVAD implantation in accordance with Ministry of Health and Ministry of Defence regulations.
Globally, tens of thousands of LVAD implants—including the HeartMate 3—have been performed successfully, with some patients living up to 15 years post-implant./.
Endoscopic surgery has now been performed in most medical specialties in Vietnam, from gastroenterology, urology, endocrinology, to thoracic surgery and traumatology, with complicated techniques used in liver resection, esophagectomy and heart valve replacement.
Central Military Hospital 108 is among the five to receive the Asia Pacific Hand Hygiene Excellence Award and Innovation Award 2021 for excellently performing hand hygiene at the recent Hand Hygiene Excellence Award Ceremony 2022 in Singapore.
Despite storm-related disruptions and flight delays, the organs were successfully transported via a combination of air and ground travel. All patients are currently stable and recovering well.
The patient, Tieu Viet But, born in 1970 and residing in Binh Tri commune, Binh Son district, the central province of Quang Ngai, was working aboard fishing vessel Qng – 95657TS when the incident occurred at 7:00 am.
All drugs entering hospitals must have a clear origin, so counterfeit drugs are only in the market, not in hospital, affirmed Minister of Health Dao Hong Lan.
To achieve its goal of becoming a developed nation by 2045, Vietnam is prioritising the integration of AI and digital tools into the training of future doctors, said Assoc. Prof. Dr. Nguyen Viet Nhung, Dean of Medicine at University of Medicine and Pharmacy, Vietnam National University (VNU) Hanoi.
Health experts called for collective disease prevention and integrated solutions to achieve zero dengue deaths in the country at an online talk show on June 14.
The PM called for closer, broader, and more effective cooperation with Vietnamese partners, guided by the principles of mutual benefit, joint efforts, shared outcomes, and common development, including promoting stronger public-private partnerships and collaboration with businesses.
Renowned for its expertise in complex surgeries, the hospital has attracted foreign patients seeking treatment for conditions such as kidney and urinary tract stones, urological and gastrointestinal cancers, and male reproductive disorders. Most procedures are performed using advanced techniques, including laparoscopy and robotic surgery. T
Leading Vietnamese companies specialising in respiratory and dermatological treatments, traditional medicine, immune support supplements, and functional foods will have an opportunity to connect with international distributors and secure export deals.
The project aimed to enable early detection and reduce the risk of dangerous complications, targeting patients with chronic diabetes, cardiovascular conditions and metabolic disorders.
A 2023 report by the Vietnam Health Economics Association estimated that the total cost of tobacco-related healthcare and economic losses reached 108 trillion VND (4.14 billion USD) annually – equivalent to 1.14% of GDP and five times higher than the budget revenue generated by the tobacco industry.
All eligible patients will receive surgical interventions and post-operative care in accordance with Vietnamese medical standards and global care protocols.
Medical screenings and surgical interventions for children with disabilities are being carried out at health centers across Dien Bien. So far this year, 242 children have been identified for diagnosis, treatment, surgery, and the provision of assistive devices.
The Red Journey has become the country’s largest and most effective blood donation campaign, leaving a strong impression on the national voluntary blood donation movement.
This case marks the ninth fetal cardiac intervention conducted in HCM City, and it was considered the most technically demanding to date due to the fetus’s extremely early gestational age and the severity of the condition as diagnosed with aortic atresia.
The groundbreaking ceremony took place one day after the VNVC Vaccine JS Company and Sanofi Group exchanged cooperation documents on vaccine production technology transfer under the witness of State President Luong Cuong and French President Emmanuel Macron.
Vietnam’s traditional medicine took centre stage at the International Congress Biopharm Nonclinical Development, BioNCiD 2025, held on May 25-26 in the Cuban city of Varadero, amid growing global interest in sustainable healthcare solutions.
Under the agreement, VNVC and Sanofi will gradually implement technology transfers to enable domestic production of several key Sanofi vaccines that are widely used in Vietnam. In addition, Sanofi will support VNVC in training human resources and quality management in vaccine research and manufacturing.
Despite the ongoing global circulation and unpredictable developments of SARS-CoV-2, the World Health Organisation (WHO) hasn’t issued new warnings about COVID-19, said the Ministry of Health.
